Skip to main content
Sister Publication Links
  • European Rubber Journal
  • Plastics News
  • Tire Business
Subscribe
  • Login
  • Register
  • Subscribe
  • News
    • Best Places to Work
    • Rubber Division IEC
    • War in Ukraine
    • Automotive
    • Tire
    • Non-Tire
    • Suppliers
    • ITEC
    • Silicone
    • Online Exclusive
    • Latex
    • Technical Notebooks
    • Executive Action
    • Government/Legal
    • Opinion
    • Blogs
    • Sustainability
    • Products
    • Wacky World of Rubber
  • Airless Tires
  • Custom
    • Sponsored Content
    • White Papers
  • Resources
    • Directory
    • Classifieds & Mold Mart
  • Data
  • Events
    • RN Events
    • RN Livestreams/Webinars
    • Industry Events
    • Past Events
    • Rubber News M&A Live
    • Ask the Expert
    • Healthcare Elastomers Conference
    • Rubber In Automotive Conference
    • Women Breaking the Mold Networking Forum
  • Advertise
  • DIGITAL EDITION
MENU
Breadcrumb
  1. Home
  2. News
September 16, 2015 02:00 AM

Acquisition expands Freudenberg Medical portfolio

Jennifer Karpus-Romain
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print
    Jorg Schneewind, president and CEO of Freudenberg Medical.

    CARPINTERIA, Calif.—Freudenberg Medical, a global developer and manufacturer of specialty components and minimally invasive products for the medical device and pharmaceutical industry, has acquired a majority of Hemoteq A.G., a provider of surface coating technologies and related services for medical devices.

    “Hemoteq's coating technology adds a key technology component to our portfolio and represents an important milestone in our long-term strategy to provide a full suite of innovative technology services to our global medical device OEM customers,” Jorg Schneewind, president and CEO of Freudenberg Medical, said in a news release.

    Under the transaction, Freudenberg Medical will acquire 75 percent of Hemoteq from shareholders Earlybird Venture Capital and Pi-nova Capital GmbH.

    The remaining shares are held by Michael Hoffmann and Roland Horres, founders of Hemoteq.

    Along with Chief Financial Officer Thomas Loewen, they will continue to manage the busi-ness.

    Max Kley, president of Freudenberg Medical Europe and Specialty Components, will become chairman of the supervisory board.

    “We identified Hemoteq as a strategic fit for the long-term development of Freudenberg Medical,” Schneewind said.

    “Freudenberg Medical's long-term strategy is to provide our OEM customers with a full suite of innovative technology services for medical device manufacturing, and surface coating is a key technology component.”

    This acquisition was not necessarily to move into new markets, he said, but “in order to offer our medical device customers a comprehensive range of services and technologies that help them to improve the efficacy of their devices, and ultimately of patient outcome.”

    Wuerselen, Germany-based Hemoteq develops coating solutions for combination products such as drug eluting stents, as well as coatings for catheters and cochlear implants. Freudenberg said Hemoteq is a market leader in drug-coated balloon catheters and holds more than 100 patents in innovative surface technologies.

    “The product and service spectrum of Hemoteq perfectly complements the capabilities of Freudenberg Medical,” Kley said in a statement.

    Hemoteq provides comprehensive services from the development of the medical device to regulatory approval and serial production. Freudenberg Medical said it develops and manufactures minimally invasive systems as well as components made of silicone, thermoplastics and specialty metals; those surfaces can be modified with active ingredient coatings for optimal efficiency of the medical device.

    “With the combination of our material and processing expertise and Hemoteq's leading coating technologies, we can provide our customers a unique portfolio of product solutions,” Hoffmann said.

    “Freudenberg Medical offers Hemoteq excellent market access to offer our solutions worldwide. The long-term orientation and financial stability of Freudenberg assures our customers that we can reliably support them over long development processes and throughout their product life cycles.”

    Schneewind said Freudenberg Medical plans to continue to seek businesses that are a strategic fit and bring complementary innovative technology.

    Freudenberg Medical, formerly Helix Medical and MedVenture Technology, is a global partner for the design, development and manufacture of medical device technologies.

    Freudenberg has more than 40,000 employees with more than 1,400 part of the Freudenberg Medical arm. Hemoteq, with a work force of 110, will retain its operation in Wuerselen.

    Related Articles
    Freudenberg-NOK to expand Findlay facility
    Freudenberg-NOK expands again; Firm to add jobs, space at Indiana operation
    Freudenberg unveils new medical brand
    Sealing the deal; Freudenberg-NOK to supply line to auto maker
    Freudenberg to restructure silicone business
    Freudenberg to restructure LSR business
    Freudenberg Medical expands in California
    Letter
    to the
    Editor

    Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].

    Most Popular
    1
    AirBoss 2022 results drop because of fall in nitrile glove needs
    2
    EU approves Yokohoma's Trelleborg Wheel Systems purchase
    3
    Inspiring tires: 5 big winners at Tire Technology International awards
    4
    Datwyler: Where could electrically conductive elastomers be used?
    5
    Pros and Cons: A look at 4 emerging sustainable carbon black methods
    SIGN UP FOR NEWSLETTERS
    EMAIL ADDRESS

    Please enter a valid email address.

    Please enter your email address.

    Please verify captcha.

    Please select at least one newsletter to subscribe.

    Get our newsletters

    Staying current is easy with Rubber News delivered straight to your inbox, free of charge.

    Subscribe Today

    Subscribe to Rubber News to get the best coverage and leading insights in the industry.

    SUBSCRIBE
    Connect with Us
    • LinkedIn
    • Facebook
    • Twitter

    MISSION

    To serve companies in the global rubber product industry by delivering news, industry insights, opinions and technical information.

    Contact Us

    2291 Riverfront Pkwy, Suite 1000
    Cuyahoga Falls,
    OH 44221

    Customer Service:
    877-320-1726

    Resources
    • About Us
    • Digital Edition
    • Staff
    • Advertise
    • Order Reprints
    • Privacy Policy
    • Privacy Request
    • Terms of Service
    • Careers
    • Ad Choices Ad Choices
    • Sitemap
    Partner Sites
    • Tire Business
    • European Rubber Journal
    • Plastics News
    • Urethanes Technology
    • Automotive News
    • Crain Brands
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Best Places to Work
      • Rubber Division IEC
      • War in Ukraine
      • Automotive
      • Tire
      • Non-Tire
      • Suppliers
      • ITEC
      • Silicone
      • Online Exclusive
      • Latex
      • Technical Notebooks
      • Executive Action
      • Government/Legal
      • Opinion
      • Blogs
        • Products
        • Wacky World of Rubber
      • Sustainability
    • Airless Tires
    • Custom
      • Sponsored Content
      • White Papers
    • Resources
      • Directory
      • Classifieds & Mold Mart
    • Data
    • Events
      • RN Events
        • Healthcare Elastomers Conference
        • Rubber In Automotive Conference
        • Women Breaking the Mold Networking Forum
      • RN Livestreams/Webinars
      • Industry Events
      • Past Events
      • Rubber News M&A Live
      • Ask the Expert
    • Advertise
    • DIGITAL EDITION